Safety and efficacy of istaroxime in patients with acute heart failure‐related pre‐cardiogenic shock – a multicentre, randomized, double‐blind, placebo‐controlled, parallel group study ( <scp>SEISMiC</scp> )-Reference-Cited by-同舟云学术

Safety and efficacy of istaroxime in patients with acute heart failure‐related pre‐cardiogenic shock – a multicentre, randomized, double‐blind, placebo‐controlled, parallel group study ( SEISMiC )

Published:2022-08-22 Issue:10 Volume:24 Page:1967-1977
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Metra Marco¹,Chioncel Ovidiu²³,Cotter Gad⁴⁵,Davison Beth⁴⁵,Filippatos Gerasimos⁶,Mebazaa Alexandre⁵⁷,Novosadova Maria⁴,Ponikowski Piotr⁸,Simmons Phillip⁹,Soffer Joseph⁹,Simonson Steven⁹

Affiliation:

1. Cardiology Unit, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health University of Brescia Brescia Italy

2. Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu' Bucharest Romania

3. University of Medicine Carol Davila Bucharest Romania

4. Momentum Research, Inc Chapel Hill NC USA

5. Cardiovascular Markers in Stress Conditions (MASCOT) Université Paris Cité; Inserm UMR‐S 942 Paris France

6. Department of Cardiology, University of Cyprus, School of Medicine & National and Kapodistrian University of Athens, School of Medicine Attikon University Hospital Athens Greece

7. Department of Anesthesiology and Critical Care and Burn Unit, Hôpital Saint‐Louis Lariboisière FHU PROMICE, DMU Parabol, APHP.Nord Paris France

8. Department of Heart Diseases Wroclaw Medical University Wrocław Poland

9. Windtree Therapeutics, Inc. Warrington PA USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2629

Reference14 articles.

1. Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology

2. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association;Van DS;Circulation,2017